Remote Ischemic Conditioning in Elective PCI?

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 22, Issue 4, 2017, Pages 310-315

  Giblett, Joel P ^a   Hoole, Stephen P ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

ischemia reperfusion injury; PCI associated myocardial infarction; percutaneous coronary intervention; remote ischemic conditioning

Indexed keywords

HEART INFARCTION; HUMAN; MEDICAL PROCEDURES; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPHYLAXIS; REMOTE ISCHEMIC CONDITIONING; REPERFUSION INJURY; REVIEW; ANIMAL; BLOOD FLOW; CARDIAC MUSCLE; ISCHEMIC PRECONDITIONING; LOWER LIMB; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOLOGY; PROCEDURES; PROTECTION; RISK FACTOR; TREATMENT OUTCOME; VASCULARIZATION;

ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING; LOWER EXTREMITY; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; PROTECTIVE FACTORS; REGIONAL BLOOD FLOW; RISK FACTORS; TREATMENT OUTCOME;

EID: 85020464618     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248417702479     Document Type: Review

References (47)

1. Murry CE, Jennings RB, Reimer KA,. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74 (5): 1124-1136.
2. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P,. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993; 87 (3): 893-899.
3. Heusch G, Bøtker HE, Przykle K, Redington A, Yellon D,. Remote ischemic conditioning. J Am Coll Cardiol. 2015; 65 (2): 177-195.
4. Hausenloy DJ, Yellon DM,. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev. 2007; 12 (3-4): 217-234.
5. Whittington HJ, Harding I, Stephenson CI, et al. Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling. Cardiovasc Res. 2013; 99 (4): 694-704.
6. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM,. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes. 2005; 54 (8): 2360-2364.
7. Stein AB, Tang XL, Guo Y, Xuan YT, Dawn B, Bolli R,. Delayed adaptation of the heart to stress: late preconditioning. Stroke. 2004; 35 (11 suppl 1): 2676-2679.
8. Meybohm P, Bein B, Brosteanu O, et al. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015; 373 (15): 1397-1407.
9. Hausenloy DJ, Candilio L, Evans R, et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015; 373 (15): 1408-1417.
10. Porto I, Selvanayagam JB, Van Gaal WJ, et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006; 114 (7): 662-669.
11. Bahrmann P, Figulla HR, Wagner M, Ferrari M, Voss A, Werner GS,. Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions. Heart. 2005; 91 (9): 1186-1192.
12. Hoole SP, Heck PM, Sharples L, Dutka DP, West NE,. Coronary stent length predicts PCI-induced cardiac myonecrosis. Coron Artery Dis. 2010; 21 (5): 312-317.
13. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012; 60 (16): 1581-1598.
14. Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005; 111 (8): 1027-1032.
15. Lansky AJ, Stone GW,. Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv. 2010; 3 (6): 602-610.
16. Kizer JR, Muttrej MR, Matthai WH, et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J. 2003; 24 (14): 1314-1322.
17. Cavallini C, Verdecchia P, Savonitto S, et al. Prognostic value of isolated troponin I elevation after percutaneous coronary intervention. Circ Cardiovasc Interv. 2010; 3 (5): 431-435.
18. Natarajan MK, Kreatsoulas C, Velianou JL, Mehta SR, Pericak D, Goodhart DM,. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. Am J Cardiol. 2004; 93 (6): 750-753.
19. Fuchs S, Kornowski R, Mehran R, et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol. 2000; 85 (9): 1077-1082.
20. Nienhuis MB, Ottervanger JP, Bilo HJ, Dikkeschei BD, Zijlstra F,. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv. 2008; 71 (3): 318-324.
21. Ndrepepa G, Colleran R, Braun S, et al. High-sensitivity troponin T and mortality after elective percutaneous coronary intervention. J Am Coll Cardiol. 2016; 68 (21): 2259-2268.
22. Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ,. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation. 2002; 106 (10): 1205-1210.
23. Gruberg L, Dangas G, Mehran R, et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 2002; 55 (1): 66-72.
24. Xu X, Zhou Y, Luo S, et al. Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug-eluting stent implantation. Angiology. 2014; 65 (8): 660-666.
25. Zografos TA, Katritsis GD, Tsiafoutis I, Bourboulis N, Katsivas A, Katritsis DG,. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention. Am J Cardiol. 2014; 113 (12): 2013-2017.
26. Hoole SP, Heck PM, White PA, et al. Stunning and cumulative left ventricular dysfunction occurs late after coronary balloon occlusion in humans insights from simultaneous coronary and left ventricular hemodynamic assessment. JACC Cardiovasc Interv. 2010; 3 (4): 412-418.
27. Maisel AS, Wettersten N, van Veldhuisen DJ, et al. Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS Study. J Am Coll Cardiol. 2016; 68 (13): 1420-1431.
28. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105 (19): 2259-2264.
29. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000; 36 (5): 1542-1548.
30. Hoole SP, Heck PM, Sharples L, et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation. 2009; 119 (6): 820-827.
31. Davies WR, Brown AJ, Watson W, et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up. Circ Cardiovasc Interv. 2013; 6 (3): 246-251.
32. Iliodromitis EK, Kyrzopoulos S, Paraskevaidis IA, et al. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning? Heart. 2006; 92 (12): 1821-1826.
33. Ghaemian A, Nouraei SM, Abdollahian F, Naghshvar F, Giussani DA, Nouraei SA,. Remote ischemic preconditioning in percutaneous coronary revascularization: a double-blind randomized controlled clinical trial. Asian Cardiovasc Thorac Ann. 2012; 20 (5): 548-554.
34. Prasad A, Gossl M, Hoyt J, et al. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial. Catheter Cardiovasc Interv. 2013; 81 (6): 930-936.
35. Ahmed RM, Mohamed el HA, Ashraf M, et al. Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention. Catheter Cardiovasc Interv. 2013; 82 (5): E647-E653.
36. Luo SJ, Zhou YJ, Shi DM, Ge HL, Wang JL, Liu RF,. Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation. Can J Cardiol. 2013; 29 (9): 1084-1089.
37. Liu Z, Wang YL, Hua Q, Chu YY, Ji XM,. Late remote ischemic preconditioning provides benefit to patients undergoing elective percutaneous coronary intervention. Cell Biochem Biophys. 2014; 70 (1): 437-442.
38. Giblett JP, West NE, Hoole SP,. Cardioprotection for percutaneous coronary intervention-reperfusion quality as well as quantity. Int J Cardiol. 2014; 177 (3): 786-793.
39. Rinaldi CA, Masani ND, Linka AZ, Hall RJ,. Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning? Heart. 1999; 81 (4): 404-411.
40. Jenkins DP, Pugsley WB, Yellon DM,. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. J Mol Cell Cardiol. 1995; 27 (8): 1623-1632.
41. Hoole SP, Khan SN, White PA, et al. Remote ischaemic pre-conditioning does not attenuate ischaemic left ventricular dysfunction in humans. Eur J Heart Fail. 2009; 11 (5): 497-505.
42. Deftereos S, Giannopoulos G, Tzalamouras V, et al. Renoprotective effect of remote ischemic post-conditioning by intermittent balloon inflations in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2013; 61 (19): 1949-1955.
43. Igarashi G, Iino K, Watanabe H, Ito H,. Remote ischemic pre-conditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease. Circ J. 2013; 77 (12): 3037-3044.
44. Er F, Nia AM, Dopp H, et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation. 2012; 126 (3): 296-303.
45. Zhou C, Jeon Y, Meybohm P, et al. Renoprotection by remote ischemic conditioning during elective coronary revascularization: a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2016; 222: 295-302.
46. Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation. 2006; 114 (18): 1955-1961.
47. Hausenloy DJ, Kharbanda R, Rahbek Schmidt M, et al. Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J. 2015; 36 (29): 1846-1848.